More about

Melanoma

News
November 02, 2024
2 min read
Save

Radioactive iodine for thyroid cancer linked to risk for melanoma, other skin cancers

Radioactive iodine for thyroid cancer linked to risk for melanoma, other skin cancers

Patients with primary thyroid cancer who received radioactive iodine exhibited increased risk for melanoma and other nonkeratinocyte skin cancers, according to study results.

News
October 22, 2024
2 min read
Save

Speaker discusses predictive power of Merlin test for low-, high-risk melanoma

Speaker discusses predictive power of Merlin test for low-, high-risk melanoma

ORLANDO — A presentation at the American Society for Dermatologic Surgery Annual Meeting detailed new data that showcased the validity of the Merlin test in identifying sentinel lymph node biopsy status in high-risk patients with melanoma.

News
October 14, 2024
2 min read
Save

Swedish study finds melanoma incidence, mortality have declined since 2015

Swedish study finds melanoma incidence, mortality have declined since 2015

The rates of melanoma incidence have significantly declined since approximately 2015 in patients aged younger than 50 years while mortality also dropped in those aged younger than 60, according to a Swedish study.

News
October 11, 2024
2 min read
Save

Secondary melanoma risk highest in Black patients

Secondary melanoma risk highest in Black patients

While Black patients are less likely to develop first melanoma than white patients, this group has a higher relative rate of secondary melanoma diagnosis, according to a study.

News
September 17, 2024
2 min read
Save

Head and neck melanoma associated with more adverse prognostic features

Head and neck melanoma associated with more adverse prognostic features

Researchers confirmed that head and neck melanomas have distinct biological characteristics that make it more adverse to patients yet more responsive to immunotherapy, according to a study.

News
September 16, 2024
2 min read
Save

Nivolumab plus ipilimumab offers ‘potential for cure’ in advanced melanoma

Nivolumab plus ipilimumab offers ‘potential for cure’ in advanced melanoma

The addition of nivolumab to ipilimumab conferred a long-term OS benefit for patients with advanced melanoma, according to study results presented at ESMO Congress.

News
September 13, 2024
1 min read
Save

‘Simple model’ helps identify melanoma recurrence

‘Simple model’ helps identify melanoma recurrence

A “simple model” known as ATLAS can help physicians detect recurrent cutaneous melanoma through symptom review, according to researchers.

News
August 12, 2024
2 min read
Save

Gene signature predicts severe adverse events from ICI therapy for melanoma

Gene signature predicts severe adverse events from ICI therapy for melanoma

Researchers identified a gene signature that can predict which group of patients with melanoma will experience severe immune-related adverse events when treated with immune checkpoint inhibitor therapy, according to a study.

News
July 30, 2024
1 min read
Save

Immunotherapy combination improves response in unresectable melanoma

Immunotherapy combination improves response in unresectable melanoma

An immunotherapy combination improved outcomes compared with historical control for certain patients with advanced melanoma, according to a topline data announcement.

News
July 06, 2024
2 min read
Save

Rosacea, melanoma linked in white patients

Rosacea, melanoma linked in white patients

Patients with rosacea have an increased risk for malignant melanoma, joint problems, metabolic disease and visual disturbances, according to a study.

View more